Department of Biomedical Engineering, University of California, Irvine, California, United States of America.
Beckman Laser Institute and Medical Clinic, University of California, Irvine, California, United States of America.
PLoS One. 2019 May 10;14(5):e0216064. doi: 10.1371/journal.pone.0216064. eCollection 2019.
We have previously demonstrated that the use of a commercially-available immersion-based optical clearing agent (OCA) enables, within 3-6 hours, three-dimensional visualization of subsurface exogenous fluorescent and absorbing markers of vascular architecture and neurodegenerative disease in thick (0.5-1.0mm) mouse brain sections. Nonetheless, the relative performance of immersion-based OCAs has remained unknown. Here, we show that immersion of brain sections in specific OCAs (FocusClear, RIMS, sRIMS, or ScaleSQ) affects both their transparency and volume; the optical clearing effect occurs over the entire visible spectrum and is reversible; and that ScaleSQ had the highest optical clearing potential and increase in imaging depth of the four evaluated OCAs, albeit with the largest change in sample volume and a concomitant decrease in apparent microvascular density of the sample. These results suggest a rational, quantitative framework for screening and characterization of the impact of optical clearing, to streamline experimental design and enable a cost-benefit assessment.
我们之前已经证明,使用市售的浸没式光学透明剂 (OCA) 可以在 3-6 小时内实现厚 (0.5-1.0mm) 小鼠脑切片中血管结构和神经退行性疾病的表面外源性荧光和吸收标记物的三维可视化。尽管如此,浸没式 OCA 的相对性能仍不清楚。在这里,我们表明,脑切片在特定的 OCA(FocusClear、RIMS、sRIMS 或 ScaleSQ)中的浸泡会影响它们的透明度和体积;光学透明效果发生在整个可见光谱范围内且是可逆的;并且 ScaleSQ 具有最高的光学透明潜力和四个评估的 OCA 的成像深度增加,尽管样品体积变化最大,同时样品的表观微血管密度降低。这些结果为筛选和表征光学透明的影响提供了一个合理的、定量的框架,以简化实验设计并实现成本效益评估。